SCHEMBL463906

SCHEMBL463906

CCCCC1(C(=O)c2cc3ccccc3[nH]2)CCNC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 0.76
SLC6A4 P31645 10/20 0.76
SLC6A3 Q01959 10/20 0.76
CYP2D6 P10635 9/20 0.76
DRD2 P14416 2/20 0.49
DRD3 P35462 1/20 0.49
MAOB P27338 1/20 0.43
HRH4 Q9H3N8 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
FLT3 P36888 1/20 0.43
KDM4E B2RXH2 3/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
DAO P14920 1/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
GAA P10253 2/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442539 0.93 SLC6A2 (0.79) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL446579 0.93 CYP2D6 (0.65) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL446379 0.86 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6MAOB
SCHEMBL441824 0.86 CYP2D6 (0.68) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL12056969 0.83 CYP2D6 (0.53) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL443933 0.79 CYP2D6 (0.87) SLC6A2SLC6A4SLC6A3CYP2D6MAOB
SCHEMBL444499 0.78 CYP2D6 (0.64) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL441274 0.78 CYP2D6 (0.64) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL441649 0.77 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3CYP2D6DRD2
SCHEMBL413412 0.75 SLC6A2 (0.72) SLC6A2SLC6A4SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF IYER PRAVIN (US) 2012-03-15 US disclosed
US-8084623-B2 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents ROCHE PALO ALTO LLC (US) 2011-12-27 US disclosed
US-8084623-B2 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents ROCHE PALO ALTO LLC (US) 2011-12-27 US disclosed
EP-2102157-B1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-06-22 EP disclosed
WO-2008074703-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-26 WO disclosed
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF CNKSR1, RB1, AR SLC6A2 4870/4885SLC6A4 4855/4885SLC6A3 4745/4885
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof CNKSR1, RB1, AR SLC6A2 4870/4885SLC6A4 4855/4885SLC6A3 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.